Obesity and Diabetes Week
Susan Hasty, Publisher
Table of Contents . . . June 23rd, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Obesity and Diabetes Week | Other Publications
Diabetes Therapy - NeuroD-betacellulin ignites islet neogenesis and reverses diabetes
Heart Disease Risk Factors - Arteriolar vasomotion found in type 1, but not type 2, diabetic patients
Diabetes Risk Factors - Diet not a major predisposing factor for diabetes in the Chinese population
Diet and Nutrition - Whole grain consumption inversely related to weight gain
Morbid Obesity - Intubating laryngeal mask airway allows airway management for morbidly obese
Type 1 Diabetes Pathogenesis - Necrosis is main type of islet cell death during development of diabetes
Diabetes Epidemiology - Diagnosis and treatment factors compound diabetes complications in Africa
Diabetes Therapy - New insulin strategies improve treatment of diabetes
Diabetic Neuropathy - Treatment of diabetic foot ulcerations reviewed
Endocrinology - PPAR-delta activates fat metabolism to prevent obesity
Genomics and Genetics - An autoimmune diabetes locus (Idd21) found on mouse chromosome 18
Gestational Diabetes - Criteria for gestational diabetes in adults may not apply to adolescents
Kidney Disease - Extracellular matrix metabolism in diabetic nephropathy reviewed
Kidney Disease - Olmesartan improves kidney function in diabetic rats
Lipid Studies - Effects of dietary fat in the diabetes diet reviewed
Obesity Pathogenesis - Obesity and type 2 diabetes in the elderly addressed
Obesity Survival and Mortality - Role in obesity in activation of renin-angiotensin system discussed
Obesity Survival and Mortality - Waist-to-height ratio accurate predictor of heart and metabolic disease risks
Obesity Therapy - Mixture of compounds exerts antiobesity effects in diabetic mice
Obesity Therapy - PPAR-gamma antagonists have potential as antiobesity and antidiabetic drugs
Type 1 Diabetes - Tetracycline moderates insulin secretion from transfected myoblasts
Type 2 Diabetes Therapy - Dipeptidyl peptidase IV inhibitors offer new therapy for type 2 diabetes
Type 2 Diabetes Therapy - Mealtime insulin lispro offers better glycemic control than glibenclamide
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
